IRIS
MONFORTE, Anna Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.161
EU - Europa 3.197
AS - Asia 1.204
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 3
OC - Oceania 1
Totale 8.574
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.143
IE - Irlanda 885
SE - Svezia 714
CN - Cina 568
UA - Ucraina 566
VN - Vietnam 507
DE - Germania 341
IT - Italia 209
FI - Finlandia 170
GB - Regno Unito 148
SG - Singapore 61
IN - India 47
RU - Federazione Russa 36
AT - Austria 33
FR - Francia 29
CZ - Repubblica Ceca 26
BE - Belgio 17
CA - Canada 17
IR - Iran 11
CH - Svizzera 4
PL - Polonia 4
CL - Cile 3
EU - Europa 3
KR - Corea 3
NL - Olanda 3
RO - Romania 3
MA - Marocco 2
SA - Arabia Saudita 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BG - Bulgaria 1
DK - Danimarca 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
JP - Giappone 1
LU - Lussemburgo 1
LV - Lettonia 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 8.574
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.075
Dublin 885
Chandler 745
Dong Ket 507
Nyköping 482
Beijing 247
Princeton 178
Ashburn 173
Cambridge 170
Medford 167
Dearborn 149
Des Moines 131
Boardman 113
Ann Arbor 86
Wilmington 60
Lancaster 49
Nanjing 40
Jinan 39
Woodbridge 39
San Mateo 38
Singapore 37
Vienna 33
Shenyang 32
Messina 31
Milan 27
Brno 26
Haikou 22
Hebei 21
Houston 19
Ningbo 19
Pune 18
Brussels 16
Los Angeles 16
Zhengzhou 15
Norwalk 14
Tianjin 14
Guangzhou 13
New York 13
Taiyuan 12
Augusta 11
Munich 11
Ardabil 10
Catania 10
Fuzhou 10
Changsha 9
Hyderabad 9
Nanchang 9
Ottawa 9
Saint Petersburg 9
Seattle 9
Taizhou 9
Auburn Hills 8
Hangzhou 8
Monmouth Junction 8
Brooklyn 7
Hefei 7
London 7
Nicotera 7
Clearwater 6
Edinburgh 6
Mcallen 6
Nuremberg 6
Washington 6
Bangalore 5
Falls Church 5
Jiaxing 5
Mumbai 5
Riva 5
Xiangfen 5
Kunming 4
Montréal 4
Nanning 4
Novokuznetsk 4
West Jordan 4
Boston 3
Brugherio 3
Como 3
Francofonte 3
Frankfurt am Main 3
Helsinki 3
Las Vegas 3
Leawood 3
New Delhi 3
Stockholm 3
Toronto 3
Bucharest 2
Carbonia 2
Changle 2
Fiorenzuola D'arda 2
Florence 2
Guspini 2
Larne 2
Lublin 2
Manchester 2
Mansfield 2
Naples 2
Pagani 2
Qingdao 2
Rome 2
Saint Louis 2
Totale 6.081
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 194
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 151
1-[3,5-bis(trifluoromethyl)phenyl]-1H,3H-thiazolo[3,4- a]benzimidazole 151
1,3-Thiazolidin-4-ones: potent and selective anti-HIV-1 agents 145
1-Aryl-1H,3H-thiazolo[3,4-a]benzimidazole derivatives 142
1-Phenyl-substituted 1H,3H-thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 141
1-fluoromethyl-1-methyl-1H,3H-thiazolo-[3,4-a]benzimidazole 139
1-Adamantanamine derivatives as potential anti-HIV agents 134
Ciclofunzionalizzazione di 1,4- e 1,5-benzodiazepine: sintesi e stereochimica di nuovi sistemi eteropoliciclici ottenuti per reazione con acidi mercaptoacetici 91
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli-sostituiti 89
Modificazioni strutturali del gruppo dichetoacido (DKA) di potenti inibitori dell'Integrasi dell'HIV-1 77
Graphene Quantum Dots Based Systems As HIV Inhibitors 76
Synthesis and anti-HIV activity of carboxylated and drug-conjugated multi-walled carbon nanotubes 73
1H,3H-Thiazolo[3,4-a]benzimidazoles and pharmaceutical compositions containing them 73
Microwave-assisted synthesis of benzimidazole and thiazolidinone derivatives as HIV-1 RT inhibitors 72
Anti-HIV agents: design and discovery of new potent RT inhibitors 68
3H-Azirino[1,2-d][1,4]benzodiazepin-4(5H)-ones: synthesis and stereochemistry 66
3-[2-(1H-1,3-benzodiazol-2-yl)ethyl]1,3-oxazolidin-2-one 65
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 65
2-(2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors 64
Compounds with potential anti-tumor activity VII. Synthesis and anti-tumor activity of 1-aryl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines 62
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 62
Annelated 1,5-benzothiazepines 62
Synthesis and metabolic study of 1H,3H-oxazolo[3,4-a]benzimidazoles, a new class of non-nucleoside HIV-1 RT-inhibitors. 61
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 61
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 61
NOVEL N1-ARYL-2- ARYLTHIOACETAMIDOBENZIMIDAZOLES WERE EFFECTIVE AGAINST HERPES SIMPLEX VIRUS 1 (HSV-1) REPLICATION IN VITRO 61
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 59
3H-AZIRINO[1,2-D][1,4]BENZODIAZEPIN-4 (5H)-ONES - SYNTHESIS AND STEREOCHEMISTRY 59
13C NMR study of tetrahydrothiazolo[3,2-d][1,4]benzodiazepin-3(2H)-ones. 58
Simulated human digestion of N1-aryl-2-arylthioacetamidobenzimidazoles and their activity against Herpes-simplex virus 1 in vitro 58
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-ones 57
HIV-1 RT inhibitors containing a cyclofunctionalized benzimidazole system 57
Sintesi e proprietà anticonvulsivanti di 3-(1,3,4-tiadiazol-2-il)tiazolidin-4-oni. 57
Antiretroviral strategy using multi-target agents 57
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 56
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitor 56
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 55
Compounds with potential antitumor activity. Note VIII 1-Alkyl-N,N'-di(1,3,4-thiadiazol-2-yl)methylenediamines. 55
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin- 4-(thi)one derivatives 54
Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents 54
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 54
Derivati benzimidazolonici ed analoghi come potenti inibitori non-nucleosidici dell'RT dell'HIV-1 54
Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation 54
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 53
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 53
Sintesi ed attività anti-HIV di 1H,3H-tiazolo[3,4-a]benzimidazoli 1-sostituiti 53
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 53
Structure-activity relationship of anti-HIV thiazolo[3,4-a]benzimidazole derivatives 53
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 53
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 52
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 52
Design, Synthesis and SAR of New Potent HIV-1 RT Inhibitors”. Antiviral Research 52
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 51
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 51
Pharmacophore-based design of HIV-1 integrase inhibitors 50
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 50
Synthesis and structural features of new cyclofunctionalized benzimidazoles 50
Synthesis and in vitro antitumour activity evaluation of 1-aryl-1H,3H-thiazolo[4,3-b]-quinazolines 50
Pharmacophore Modeling, Docking Experiments And Discovery Of New Hiv-1 NNRTIs 50
Synthesis and anti-HIV activity of TBZ structurally-related 1,2-substituted benzimidazoles 50
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 50
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 50
Synthesis and antitumour activity of 1H,3H-thiazolo[3,4- a]benzimidazole derivatives 49
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 49
ANTI-HIV AGENTS .3. SYNTHESIS AND IN-VITRO ANTI-HIV ACTIVITY OF NOVEL 1H,3H-THIAZOLO[3,4-A]IMIDAZO[4,5-B]PYRIDINES 49
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 48
Design e Sintesi di composti a struttura 3-Indol-Gliossilamidica come potenziali inibitori dell'integrasi dell'HIV-1. 48
TBZ-analoghi inibitori non nucleosidici della HIV-RT 48
Compounds with potential antitumor activity. VI - 2-Alkyl-3-[2-(1,3,4-thiadiazolyl)]-4-thiazolidinones. 48
HIV-1 integrase strand transfer inhibitors (INSTIs): design, synthesis and biological activity 48
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 48
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 48
NOVEL PYRROLO- AND THIAZOLO-IMIDAZOLES 48
Progettazione, Sintesi e SAR di analoghi 1,3-diidro-benzimidazoloni come nuovi agenti anti-HIV 48
Progettazione e Sintesi di Nuovi Inibitori dell'Integrasi dell'HIV-1 47
Synthesis and SAR of new 1,3-dihydro-benzimidazolone analogues as non-nucleoside reverse transcriptase inhibitors (NNRTIs) 47
Anti-HIV agents II. Synthesis and in vitro anti-HIV activity of novel 1H,3H-thiazolo[3,4-a]benzimidazoles. 47
Anti-HIV agents .4. Synthesis and in vitro anti-HIV activity of novel 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4- a]benzimidazoles 47
Anti-HIV agents: design and discovery of new potent RT inhibitors 46
Sintesi ed attività anti-HIV di derivati 4-tiazolidinonici. 46
MOLECULAR MODELING STUDIES AND SYNTHESIS FOR THE DISCOVERY OF HIV-1 IN-LEDGF/P75 INTERACTION INHIBITORS 46
SYNTHESIS AND ANTITUMOR-ACTIVITY EVALUATION OF 1- [(ARYLIDENE)AMINO]ADAMANTANES 46
Searching for novel N1-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors 46
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 45
Synthesis and biological activity of novel non-nucleoside HIV-1 RT inhibitors 45
Novel targets for HIV therapy: small molecules blocking IN-LEDGF/p75 interaction 45
Anti-HIV agents. V. Synthesis, structure and in vitro anti-HIV activity of novel 1H,3H-naphtho[2 ',3 ': 4,5]imidazo[1,2- c]thiazoles 45
Ligand-based drug design and docking studies of HIV-1 non-nucleoside RT inhibitors 45
Molecular Modeling, synthesis and SAR of anti-HIV agents 44
Synthesis, structural features and anti-HIV activity of TBZ analogues. 44
Structural optimization of N1-aryl-benzimidazoles for the discovery of new non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains 44
Synthesis and anti-HIV activity of TBZ structurally-related 1,2-substituted benzimidazoles 44
Design, synthesis and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents 43
Synthesis and biological activity of novel 1H,3H-thiazolo[3,4- a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors 42
NNRTI TBZ analoghi: progettazione razionale, sintesi e SAR. 42
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 42
Design e sintesi di nuovi inibitori dell'integrasi dell'HIV-1 42
Molecular Modeling Studies: Discovery of Novel Potent Non-Nucleoside RT Inhibitors 42
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 42
Totale 6.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.005
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.005
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.602 338 154 6 140 6 153 202 180 14 174 231 4
2020/20211.576 160 2 230 30 22 154 8 169 14 142 109 536
2021/20221.057 14 229 26 32 78 8 69 40 28 10 155 368
2022/20232.881 237 216 122 228 255 300 80 180 1.124 12 93 34
2023/2024545 58 101 41 93 52 84 1 23 2 29 12 49
2024/202551 51 0 0 0 0 0 0 0 0 0 0 0
Totale 8.710